Bipolar Disorder Trial, Recruiting NCT06641726 Sponsor: Akrivia Health Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06641726
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Mental Health group:

  • You have an electronic health record with a primary care (e.g. GP) or secondary care (e.g. hospital) service
  • You have been diagnosed with, or received treatment or a referral for, major depression, bipolar disorder, or schizophrenia
  • You are 18 years old or over (there is no upper age limit)
  • You can speak English

Dementia group:

  • You are 18 years old or over (there is no upper age limit)
  • You are currently alive and are, or have been, a patient under old age psychiatry services
  • You have been diagnosed with dementia, mild memory problems, or subjective memory concerns, OR you have been referred to a memory clinic
  • You are willing and able to complete a short memory and thinking assessment (confirm with trial site)

Who may not be able to join:

Mental Health group:

  • People who do not have the mental capacity to give their own consent to take part

Dementia group:

  • People who cannot understand spoken or written English
  • People who have an intellectual (learning) disability
  • People whose dementia is caused by certain specific conditions, including Creutzfeldt-Jakob disease (CJD), Huntington's disease, HIV, alcohol use, traumatic brain injury, or intellectual disability
  • People with mild memory problems (MCI) or subjective memory concerns (SCI) who have also been diagnosed with depression, psychosis, or bipolar disorder before their memory diagnosis (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Prof. James Walters, Cardiff University

Phone: (44) 7827018555

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Akrivia Health
Registry
ClinicalTrials.gov
Start date
16 May 2025
Est. completion
1 January 2035

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Diagnosis of participants with schizophrenia, bipolar disorder or schizoaffective disorder

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov